Andersen and Dopharma announce the signing of a Joint Venture agreement for the marketing of their veterinary pharmaceutical products in Spain through a new company named  Dopharma Iberia.

Andersen, a veterinary pharmaceutical company with 45 years of experience since the beginning of its operations in Spain and export markets, also has a strong focus on excellence and specialization in nutritional products.

Dopharma, a Dutch veterinary pharmaceutical company with a focus on livestock, has been active for 50 years in the market and is currently selling its products in more than 80 countries around the world with approximately 70 distribution partners.

The combination of both portfolio’s, skills and expertise is joined now in Dopharma Iberia and will enforce their presence in the Spanish market and abroad.

The portfolio of Dopharma Iberia will consist of products for livestock including poultry, bovine, equine and swine. It includes both oral and injectable formulations.

Dopharma Iberia will start with their commercial operations in September 2019.

For any questions about the above announcement or our products please contact us: [email protected]

 

From September 11-13, 2019 the European Bovine Congress will take place in ‘s-Hertogenbosch, the Netherlands. The theme is ‘your veterinary toolbox 2025’. Through technical and strategical sessions, new developments in the dairy industry and the veterinarians work field will be discussed.

Dopharma will be present with a booth.

Read the European Bovine Congress 2019 newsletter here.

More information about the congress is available on the European Bovine Congress website. Here you can also find the preliminary program.

 

Despite the rise of vegetarianism and veganism in Europe, animal-source foods currently remain our only option for meeting the nutrient demands of a growing global population.

Animal protein is particularly important in developing countries where undernutrition is high, but widespread access to affordable and safe meat, fish, milk and eggs in Europe has also contributed to our nutrition security – and our freedom to choose a diverse diet.

Key factors in the high food safety standards that we enjoy in Europe are rigorous health policies and a robust animal health sector that provides effective animal medicines, and a culture of constant innovation.
Yet the role of animal health in guaranteeing affordable, healthy food in Europe is often misunderstood and under-valued.

 

Read the full article, written by Wijnand  de Bruijn, Dopharma’s CEO Business and President of Animal Health Europe, on the website of Euronews.com.

 

Boehringer Ingelheim and Dopharma announce a pre-signing for the acquisition of BI’s production site in Saint-Herblon. The proposed sale of the Saint-Herblon (France, Loire-Atlantique) production site had been announced in October 2017 following the presentation of Boehringer Ingelheim Animal Health strategic orientations. Now, one year later, we can announce that Dopharma is to make a significant addition to its manufacturing capabilities by purchasing assets from Boehringer Ingelheim.

Read the full press release here.